Pfizer’s Obesity Pipeline Poised to Challenge Novo Nordisk
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Understand what the zero-based budgeting method is and how it can help you control your spending. This approach optimizes your finances.
15,911 articlesPfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Investing in AI can feel like riding a hype wave. This article digs into what makes a stock a true money-maker, unvei...
Is SpaceX a smarter buy than the Magnificent Seven it briefly rivaled in market value? This analysis weighs growth, p...
The FDA has issued a recall of Elite Treats Chicken Chips for Dogs due to potential salmonella contamination. No illn...
A biotech growth stock has surged 70% this year as it heads into pivotal phase 3 data and regulatory steps. Here’s wh...
Hong Kong lays out plans to connect a new digital bond platform with regional tokenization hubs, moving from pilots t...
AI-driven data centers are fueling a power supercycle, pushing on-site generation and turbocharging turbine prices. G...
Intel's shares have surged about 90% in the past year, but the real test lies in whether this comeback can endure thr...
Meta is pursuing prediction markets, signaling a major shift away from its metaverse push. The move could reshape its...
Molson Coors shares fell sharply after a disappointing quarter and a formal downgrade from a major bank. This article...
When chip stocks swing, choosing the right side matters. This guide weighs Nvidia vs AMD after the sell-off, with num...
The software sector has faced a sharp pullback, but not all names belong in the same bucket. This guide highlights ho...